(redirected from thromboangiitis obliterans)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to thromboangiitis obliterans: arteriosclerosis obliterans
References in periodicals archive ?
Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the European Medicines Agency (EMA) has granted Advanced Therapy Medicinal Product classification for its novel stem cell drug ' Stempeucel ' which will be used for the treatment of Thromboangiitis Obliterans (TAO).
Olin JW: Thromboangiitis obliterans (Buerger's Disease).
It develops and markets autologous bone marrow-derived progenitor cells as regenerative therapeutics for cardiovascular diseases focusing on ischemic heart disease (Acute Myocardial Infarction and Chronic Ischemic Heart Disease), and Thromboangiitis Obliterans, or Buerger's Disease.